BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17854757)

  • 1. Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis.
    Tan HK; Schmidt D; Stanford M; Teär-Fahnehjelm K; Ferret N; Salt A; Gilbert R;
    Am J Ophthalmol; 2007 Nov; 144(5):648-653. PubMed ID: 17854757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term ocular prognosis in 327 children with congenital toxoplasmosis.
    Wallon M; Kodjikian L; Binquet C; Garweg J; Fleury J; Quantin C; Peyron F
    Pediatrics; 2004 Jun; 113(6):1567-72. PubMed ID: 15173475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
    Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
    Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey.
    Stanford MR; Tan HK; Gilbert RE
    Br J Ophthalmol; 2006 Dec; 90(12):1464-7. PubMed ID: 16899532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis.
    Brézin AP; Thulliez P; Couvreur J; Nobré R; Mcleod R; Mets MB
    Am J Ophthalmol; 2003 Jun; 135(6):779-84. PubMed ID: 12788116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe.
    Gilbert RE; Freeman K; Lago EG; Bahia-Oliveira LM; Tan HK; Wallon M; Buffolano W; Stanford MR; Petersen E;
    PLoS Negl Trop Dis; 2008 Aug; 2(8):e277. PubMed ID: 18698419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular manifestations in congenital toxoplasmosis.
    Kodjikian L; Wallon M; Fleury J; Denis P; Binquet C; Peyron F; Garweg JG
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):14-21. PubMed ID: 15906073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study.
    Freeman K; Tan HK; Prusa A; Petersen E; Buffolano W; Malm G; Cortina-Borja M; Gilbert R;
    Pediatrics; 2008 May; 121(5):e1215-22. PubMed ID: 18426852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasmic Retinochoroiditis: Clinical Characteristics and Visual Outcome in a Prospective Study.
    Aleixo AL; Curi AL; Benchimol EI; Amendoeira MR
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004685. PubMed ID: 27136081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eccentric fixation patterns, clinical findings, and reading speed in patients with bilateral toxoplasmic macular retinochoroiditis.
    Antunes-Foschini RMS; Ho W; Messias A
    Arq Bras Oftalmol; 2018; 81(5):401-407. PubMed ID: 30208142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The visual field in toxoplasmic retinochoroiditis.
    Stanford MR; Tomlin EA; Comyn O; Holland K; Pavesio C
    Br J Ophthalmol; 2005 Jul; 89(7):812-4. PubMed ID: 15965156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eye manifestations of congenital toxoplasmosis.
    Mets MB; Holfels E; Boyer KM; Swisher CN; Roizen N; Stein L; Stein M; Hopkins J; Withers S; Mack D; Luciano R; Patel D; Remington JS; Meier P; McLeod R
    Am J Ophthalmol; 1997 Jan; 123(1):1-16. PubMed ID: 9186091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular Outcome of Brazilian Patients With Congenital Toxoplasmosis.
    Lago EG; Endres MM; Scheeren MFDC; Fiori HH
    Pediatr Infect Dis J; 2021 Jan; 40(1):e21-e27. PubMed ID: 33060522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ocular manifestations of congenital infection: a study of the early effect and long-term outcome of maternally transmitted rubella and toxoplasmosis.
    O'Neill JF
    Trans Am Ophthalmol Soc; 1998; 96():813-79. PubMed ID: 10360309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Toxoplasmic Retinochoroiditis in an Australian Adult Population: A Community-Based Study.
    Ferreira LB; Furtado JM; Charng J; Franchina M; Matthews JM; Molan AAL; Hunter M; Mackey DA; Smith JR
    Ophthalmol Retina; 2022 Oct; 6(10):963-968. PubMed ID: 35568370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eye manifestations of congenital toxoplasmosis.
    Mets MB; Holfels E; Boyer KM; Swisher CN; Roizen N; Stein L; Stein M; Hopkins J; Withers S; Mack D; Luciano R; Patel D; Remington JS; Meier P; McLeod R
    Am J Ophthalmol; 1996 Sep; 122(3):309-24. PubMed ID: 8794703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of ocular toxoplasmosis patients reported at a tertiary center in the northeast of Iran.
    Hosseini SM; Moghaddas E; Sharifi K; Dadgar Moghaddam M; Shamsian SA
    Int Ophthalmol; 2018 Dec; 38(6):2527-2533. PubMed ID: 29335806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children.
    Faucher B; Garcia-Meric P; Franck J; Minodier P; Francois P; Gonnet S; L'ollivier C; Piarroux R
    J Infect; 2012 Jan; 64(1):104-9. PubMed ID: 22051915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Ocular Outcomes in Congenital Toxoplasmosis Treated Perinatally.
    Journé A; Garweg J; Ksiazek E; Peyron F; Binquet C; Wallon M
    Pediatrics; 2024 Apr; 153(4):. PubMed ID: 38454832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual function and macular architecture in patients with inactive zone 2 and 3 toxoplasmic retinochoroiditis.
    Azevedo MH; Moura GL; Camilo EN; Muccioli C; Arantes TE
    Arq Bras Oftalmol; 2015; 78(5):273-7. PubMed ID: 26466223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.